GoodRx Holdings, Inc. (GDRX) › Shareholders' EquityGoodRx Holdings, Inc. (GDRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$31.75M2018: -$1.16B2019: -$1.09B2020: $711.36M2021: $831.68M2022: $814.83M2023: $761.96M2024: $724.66M2025: $616.26M$616.26M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$616.26M-15.0%2024$724.66M-4.9%2023$761.96M-6.5%2022$814.83M-2.0%2021$831.68M+16.9%2020$711.36M+165.4%2019-$1.09B+6.4%2018-$1.16B-3560.8%2017-$31.75M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share